Structure Therapeutics Inc.
Ownership
Ownership Structure
Who owns Structure Therapeutics Inc. (GPCR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.6% of the shares are freely tradable; institutional investors hold 96.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 11.78 | 8,403,449 | -3.5 | 03/31/2026 |
| Wellington Management Company LLP | 10.35 | 7,379,433 | +1.6 | 06/30/2026 |
| venBio Select Advisor LLC | 9.19 | 6,555,555 | +0.0 | 03/31/2026 |
| HHG PLC | 7.51 | 5,354,981 | +5.2 | 03/31/2026 |
| Deep Track Capital, LP | 6.65 | 4,740,072 | +10.8 | 06/30/2026 |
| Bvf Inc | 4.85 | 3,459,358 | -0.6 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 3.23 | 2,305,457 | +10.4 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 2.81 | 2,000,696 | +19.7 | 03/31/2026 |
| Principal Financial Group Inc | 2.46 | 1,752,753 | -0.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Health Care Inv | 4.08 | 2,909,218 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Coll Crespo Blas | CHIEF MEDICAL OFFICER | 258,228 | 8,082,536 $ | Sep 21, 2026 | direct |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | 228,960 | 7,166,448 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Other | 12,024 | 0.00 | – |
| Sep 18, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Other | 10,626 | 11.67 | 124,005 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Other | 17,817 | 0.00 | – |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Other | 17,817 | 0.34 | 6,058 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Other | 11,817 | 0.00 | – |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Other | 11,817 | 0.34 | 4,018 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.